Capsaicin and Lavender drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Capsaicin (capsicum) and Lavender (lavender). Common drug interactions include weight increased among females.

The phase IV clinical study analyzes what interactions people have when they take Capsaicin and Lavender. It is created by eHealthMe based on reports of 50 people who take the same drugs from the FDA, and is updated regularly.

What is Capsaicin?

Capsaicin has active ingredients of capsicum. eHealthMe is studying from 568 Capsaicin users. Check the latest studies of Capsaicin.

What is Lavender?

Lavender has active ingredients of lavender. eHealthMe is studying from 335 Lavender users. Check the latest studies of Lavender.



On Jul, 07, 2026

50 people who take Capsaicin and Lavender together, and have interactions are studied.

Capsaicin and Lavender drug interactions.

What are the common drug interactions of Capsaicin and Lavender, by gender? *:

female:

  1. Weight increased
  2. Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
  3. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  4. Thrombocytopenic purpura (a bleeding disorder in which the immune system destroys platelets)
  5. Suicidal ideation
  6. Burning sensation
  7. Drug ineffective

male:

n/a

What are the common drug interactions of Capsaicin and Lavender, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Weight increased
  2. Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
  3. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  4. Thrombocytopenic purpura (a bleeding disorder in which the immune system destroys platelets)
  5. Suicidal ideation

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Burning sensation
  2. Drug ineffective

What are the existing conditions these people have? *

  1. Complex Regional Pain Syndrome (long lasting pain condition most often affecting one of the limbs (arms, legs, hands, or feet)): 49 people, 98.00%

* Approximation only. Some reports may have incomplete information.

Do you take Capsaicin and Lavender?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Capsaicin and Lavender:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Capsaicin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lavender:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Capsaicin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lavender and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on capsicum and lavender (the active ingredients of Capsaicin and Lavender, respectively), and Capsaicin and Lavender (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: